• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$39.87 -$0.04 (-0.10%)

REAL-TIME: Last trade at

Cubist Pharmaceuticals, Inc.

NASDAQ:CBST

Jump to this page for:

Related Resources

Cubist Pharmaceuticals Marks 20th Anniversary by Making Its Largest-Ever Commitment to STEM Programs

5/16/2012 by PharmiWeb.com - UK

Cubist Pharmaceuticals Marks 20th Anniversary by Making Its Largest-Ever Commitment to STEM Programs

5/16/2012 by Business Wire

Cubist announces presentations of data from phase 2 studies of CB-5945

5/14/2012 by Theflyonthewall.com

Cubist Announces First Scientific Presentations of Phase 2 Data for CB-5945 in the Treatment of Opioid-Induced Constipation

5/14/2012 by Business Wire

Vertex Leads A Big Week For Biotechs

5/9/2012 by Investor's Business Daily

Cubist management to meet with RBC Capital

4/20/2012 by Theflyonthewall.com

Needham & Company maintains a 'Hold' on Cubist Pharmaceuticals (CBST); Cubicin Sales Beat; Awaiting Progression

4/19/2012 by StreetInsider.com

Cubist Pharmaceuticals Reports First Quarter 2012 Financial Results

4/19/2012 by PharmiWeb.com - UK

Cubist raises FY12 revenue view to $900M-$930M, consensus $907.59M

4/18/2012 by Theflyonthewall.com

Cubist Pharmaceuticals, Inc. (CBST) Tops Q1 EPS by 1c

4/18/2012 by StreetInsider.com

Cubist reports Q1 EPS 45c, consensus 44c

4/18/2012 by Theflyonthewall.com

Cubist Pharmaceuticals Reports First Quarter 2012 Financial Results

4/18/2012 by Business Wire

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

4/18/2012 by 24/7 Wall Street

5 Stocks Poised to Pop on Earnings

4/18/2012 by TheStreet.com

Cubist announces positive results from Entereg Phase 4 study

4/17/2012 by Theflyonthewall.com

Cubist Announces Positive Results from ENTEREG® Phase 4 Study in Patients Undergoing Radical Cystectomy

4/17/2012 by Business Wire

Cubist Pharmaceuticals (CBST) Initiated As 'Hold' By Brean Murray

4/4/2012 by iStockAnalyst

Oppenheimer Raises PT and Estimates on Cubist Pharmaceuticals (CBST); Guidance Likely Conservative

4/4/2012 by StreetInsider.com

Oppenheimer Raises PT On Cubist Pharmaceuticals (CBST) To $49

4/4/2012 by iStockAnalyst

Brean Murray Carret & Co. Starts Cubist Pharmaceuticals (CBST) at Hold; Waiting Until Next Growth Driver

4/4/2012 by StreetInsider.com

Cubist guidance likely to increase throughout 2012, says Oppenheimer

4/4/2012 by Theflyonthewall.com

Cubist initiated with a Hold at Brean Murray

4/4/2012 by Theflyonthewall.com

Cubist Pharmaceuticals to Announce Q112 Financial Results on Wednesday, April 18th, 2012

4/2/2012 by PharmiWeb.com - UK

Cubist Pharmaceuticals to Announce Q112 Financial Results on Wednesday, April 18th, 2012

4/2/2012 by Business Wire

Questcor, Medical Firms Keep Small Cap Leaders Healthy

3/30/2012 by Investor's Business Daily

ThinkEquity Starts Cubist Pharmaceuticals (CBST) at Buy

3/23/2012 by StreetInsider.com

Top Analyst Upgrades & Downgrades (AET, MO, CVH, CBST, DFS, EXM, HFC, MWW, RAI, XLNX, ZNGA)

3/23/2012 by 24/7 Wall Street

Cubist initiated with a Buy at ThinkEquity

3/23/2012 by Theflyonthewall.com

Product Profiles: Pipeline Antibacterials - Gram-Negative Combination Antibiotics Show Promise in MRSA-Focused Pipeline

3/19/2012 by PR Newswire

Cubist Opens Expanded Research and Development Facility

3/16/2012 by Business Wire

Cubist Pharmaceuticals Appoints Jane Henney to Board of Directors

3/9/2012 by Genetic Engineering News

Cubist Pharmaceuticals Appoints Jane Henney to Board of Directors

3/9/2012 by Business Wire

IBD Tech Stock Screen: 5 Top Meds Start With Questcor

3/2/2012 by Investor's Business Daily

Cubist Pharmaceuticals to Present at February/March Investor Conferences

2/20/2012 by PharmiWeb.com - UK

Cubist Pharmaceuticals to Present at February/March Investor Conferences

2/20/2012 by Business Wire

Small Cap Screen: Buffalo Wild, Stone Energy Lead

2/17/2012 by Investor's Business Daily

Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors

2/16/2012 by PharmiWeb.com - UK

Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors

2/16/2012 by Business Wire

A Forward Look, The Year Ahead - Featured Research on Momenta Pharmaceuticals, Inc. and Cubist Pharmaceuticals Inc

2/15/2012 by Broadcast Newsroom

A Forward Look, The Year Ahead - Featured Research on Momenta Pharmaceuticals, Inc. and Cubist Pharmaceuticals Inc

2/15/2012 by Marketwire
See More Articles...